ABSTRACT
[Objective]Using intradermal injection in the clip ridge holes and pain points combined oral drug cured remaining neuralgia after herpes zoster to observe the clinical curative effect.[Methods] 76 patients diagnosed with remaining neuralgia after herpes zoster in traces of chest and back were randomly divided into 40 cases of observation group and 36 cases of control group,the observation group was to use intradermal injection in the clip ridge holes and pain points combined oral drug,which was gabapentin cobalt and methyl amine pills.The control group was to use oral gabapentin cobalt and methyl amine pills.Observing two groups before and after the treatment with blurred vision score(VAS) and quality of sleep score(QS) was to comprehensively evaluate the efficacy of treatment.[Result] The VAS score during the period of the two groups after treatment was significantly decreased and the sleep quality score was significantly increased;After treatment,the VAS score of observation group was significantly lower than the VAS score of control group in the same period,but the sleep quality score of observation group was significantly higher than the sleep quality score of control group in the same period.The observation group was significantly higher than the control group in clinical effectiveness.[Conclusion] It had good clinical effect to use intradermal injection in the clip ridge holes and pain points combined oral drug to cure remaining neuralgia after herpes zoster in traces of chest and back.It could quickly relieve pain symptoms and improve sleep quality,so it was a kind of effective method for the treatment of remaining neuralgia after herpes zoster.
ABSTRACT
Objective]Observe clinical efficacy of herpes zoster treated by the compound radix scutellariae solution wet application. [Method]50 patients were randomly divided into 25 cases of the compound radix scutellariae group and 25 cases of the nitrofurazone group, respectively given wet application of the compound radix scute-llariae solution and nitrofurazone solution, at the same time given intravenousganciclovir 0.3g/time,1 time/d, oral vitamin B1 20mg/time, 3 times/d, oral cobalt amine 0.5mg/time, 3 times/d, one week as a period. Record all patients' pain, skin lesion scores before the treatment and in the course of the third, fifth, seventh day and record the time of herpes stopping hair, blister drying up, blister beginning to scab and the scabby area not less than 50%.[Result] Pain, skin lesion scores of the compound radix scutellariae group were signifycantly lower than those of nitrofurazone group, the time of herpes stopping hair, blister drying up, blister beginning to scab and the scabby area not less than 50% of the compound radix scutellariae group compared with nitrofurazone group in advance, the difference was statistically significant(P<0.05). [Conclusion]Treatment of the compound radix scutellariae solution to herpes zoster had distinct clinical efficacy, having significant advantages in terms of alleviating pain and promoting skin lesions subsided.
ABSTRACT
OBJECTIVES: This study aimed to develop and validate a simple questionnaire for chronic neuropathic pain that can be administered as a screening tool by general practitioners and internists in order to help them identify patients with probable neuropathic pain. METHODS: Following a development phase and a pilot study, the revised version of the screening tool which included eleven descriptors associated with neuropathic pain both in English and Filipino languages was validated on 120 consecutive patients with any type of pain except psychogenic pain, recruited in the out-patient clinics of six hospitals. The questionnaire was validated by assessing the sensitivity, specificity, positive and negative predictive value of each item and the overall questionnaire. The internal consistency of the questionnaire items was assessed using the Kuder-Richardson formula 20. RESULTS: Overall, the internal consistency of the SigN-PQ using the Kuder-Richardson formula 20 was 0.7837; the sensitivity was 91.89% with specificity of 80.22%, PV (+) was 65.38% and PV(-) was 96.0%. For the English version, the descriptors with the highest scores were burning (Sensitivity: 100%, Specificity: 93%) and electricity-like (Sensitivity: 100%, Specificity: 93%). For the Filipino version, mainit (burning) has the highest sensitivity of 88% with specificity of 82.6%, followed by gumagapang (tingling) with sensitivity of 86.96% and specificity of 85.42%. The sensation of saksak (stabbing) and hiwa (lancinating) have the lowest sensitivity, 60% and 54% respectively, although their specificity scores are high. Since this study is a validation of a screening tool for neuropathic pain, the investigators decided to choose descriptors with higher sensitivity. Thus, in the final version of the SignN-PQ, the descriptors saksak and hiwa were removed. CONCLUSION: The SigN-PQ Neuropathic Pain Questionnaire has a high overall sensitivity of 91.89% and specificity of 80.22%. The pain descriptors in the questionnaire are consistent with the descriptors cited in the literature. It is a valid screening instrument for neuropathic pain that can be easily incorporated in the daily practice of general practitioners and internists.